What is the Johnson&Johnson Patient Assistance Foundation?
Johnson & Johnson Patient Assistance Foundation, Inc. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson.
How can I get additional support with Stelara®?
Janssen CarePath provides the additional support you may need to help you get started with STELARA ® treatment, once you and your doctor have decided that STELARA ® is right for you. A personally assigned Janssen CarePath Care Coordinator will work closely with you and your doctor to provide the support you need.
What is jjpaf and how do I apply?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
Which conditions should not be treated with Stelara ®?
In patients with ulcerative colitis, these included gastroenteritis, ophthalmic herpes zoster, pneumonia, and listeriosis. Treatment with STELARA ® should not be initiated in patients with a clinically important active infection until the infection resolves or is adequately treated.
See more
We will review your application
Once we receive your application, it will take about three days to review. If the application is missing information, it will take longer. Upon completion of review, we’ll send you a letter to let you know whether you’re eligible. When you apply, please be sure to include all your supporting documents.
You can reapply each year
Once approved, you’ll receive the medicines you need for up to one year. Before your enrollment ends, we’ll send you a reminder to renew your application for next year.
Are you taking other HIV medications that are not covered in this program?
If so, please go to the HarborPath website to access the HarborPath Patient Application.
What is a stalera?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease.
Can you discontinue Stelara?
Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with STELARA ®. If an anaphylactic or other clinically significant hypersensitivity reaction occurs , institute appropriate therapy and discontinue STELARA ® .
Can you take stelara with methotrexate?
STELARA ® (ustekinumab) is indicated for the treatment of adult patients with active psoriatic arthritis. STELARA ® can be used alone or in combination with methotrexate (MTX).
Can you administer stalara to TB patients?
Evaluate patients for TB prior to initiating treatment with STELARA ®. Do not administer STELARA ® to patients with active tuberculosis infection . Initiate treatment of latent TB before administering STELARA ®. Closely monitor patients receiving STELARA ® for signs and symptoms of active TB during and after treatment.
Is PRES a reversible encephalopathy?
Two cases of posterior reversible encephalopathy syndrome (PRES), also known as Reversible Posterior Leukoencephalopathy Syndrome (RPLS), were reported in clinical trials. Cases have also been reported in postmarketing experience in patients with psoriasis, psoriatic arthritis and Crohn’s disease. Clinical presentation included headaches, seizures, confusion, visual disturbances, and imaging changes consistent with PRES a few days to several months after ustekinumab initiation. A few cases reported latency of a year or longer. Patients recovered with supportive care following withdrawal of ustekinumab.
Is stalara contraindicated?
STELARA ® (ustekinumab) is contraindicated in patients with clinically significant hypersensitivity to ustekinumab or to any of the excipients.
How long after stopping stalara can you get BCG?
You should not receive the BCG vaccine during the one year before receiving STELARA® or one year after you stop receiving STELARA®. have any new or changing lesions within psoriasis areas or on normal skin. are receiving or have received allergy shots, especially for serious allergic reactions. receive or have received phototherapy ...
How old do you have to be to get psoriasis treatment?
adults and children 6 years and older with moderate to severe psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
Can you get a lung infection with stalara?
Cases of lung inflammation have happened in some people who receive STELARA ® and may be serious. These lung problems may need to be treated in a hospital. Tell your doctor right away if you develop shortness of breath or a cough that doesn’t go away during treatment with STELARA ® .
Can you get a rash from a stala?
Serious allergic reactions can occur. Stop using STELARA ® and get medical help right away if you have any symptoms of a serious allergic reaction such as: feeling faint, swelling of your face, eyelids, tongue, or throat, chest tightness, or skin rash.
Does STELARA cause death?
People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL‐12) and interleukin 23 (IL‐23) are at a higher risk for certain serious infections that can spread throughout the body and cause death. People who take STELARA ® may also be more likely to get these infections.
What is JJPAF in medicine?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is JJPAF?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is PPA in healthcare?
The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.
What is Janssen committed to?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.